BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20185705)

  • 1. Medicine. Keeping tabs on tumor DNA.
    Kaiser J
    Science; 2010 Feb; 327(5969):1074. PubMed ID: 20185705
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating methylated DNA.
    Herman JG
    Ann N Y Acad Sci; 2004 Jun; 1022():33-9. PubMed ID: 15251936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic sequencing of circulating tumor DNA: novel noninvasive cancer biomarker.
    Lianos GD; Mangano A; Kouraklis G; Roukos DH
    Biomark Med; 2014; 8(5):629-32. PubMed ID: 25123031
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA.
    Rago C; Huso DL; Diehl F; Karim B; Liu G; Papadopoulos N; Samuels Y; Velculescu VE; Vogelstein B; Kinzler KW; Diaz LA
    Cancer Res; 2007 Oct; 67(19):9364-70. PubMed ID: 17909045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation?
    Bunn PJ
    J Clin Oncol; 2003 Nov; 21(21):3891-3. PubMed ID: 14507944
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
    Schwarzenbach H; Müller V; Stahmann N; Pantel K
    Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracellular DNA in plasma--a potential diagnostic marker in oncology].
    Gaziev AI; Shaĭhaev GO; Korenev SV
    Vopr Onkol; 2008; 54(5):545-54. PubMed ID: 19069466
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of methylated circulating DNA in cancer patients' blood.
    Sunami E; Vu AT; Nguyen SL; Hoon DS
    Methods Mol Biol; 2009; 507():349-56. PubMed ID: 18987826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.
    Frattini M; Balestra D; Verderio P; Gallino G; Leo E; Sozzi G; Pierotti MA; Daidone MG
    J Clin Oncol; 2005 May; 23(13):3163-4; author reply 3164-5. PubMed ID: 15860889
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations.
    Garcia JM; Silva JM; Dominguez G; Silva J; Bonilla F
    Genes Chromosomes Cancer; 2001 Jul; 31(3):300-1. PubMed ID: 11391802
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
    Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
    Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative analysis of circulating DNA in serum of cancer patients].
    Tu H; Gao HF; Fu SL; Chen H
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):606-8. PubMed ID: 15634521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour-derived predictive biomarkers in oncology.
    Hodgson DR; Wellings R; Orr MC; McCormack R; Malone M; Board RE; Cantarini MV
    Drug Discov Today; 2010 Feb; 15(3-4):98-101. PubMed ID: 20045486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases].
    Jäger U; Laczika K; Scholten C; Mitterbauer M; Novak M; Lechner K
    Wien Klin Wochenschr; 1996; 108(20):634-9. PubMed ID: 9005678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for isolation and genetic analysis of circulating tumor DNA in patient plasma.
    Kawaguchi T; Holland WS; Gumerlock PH
    Methods Mol Med; 2003; 85():257-62. PubMed ID: 12710213
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating tumor cells: will they be clinically useful?
    Nelson NJ
    J Natl Cancer Inst; 2010 Feb; 102(3):146-8. PubMed ID: 20107163
    [No Abstract]   [Full Text] [Related]  

  • 17. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
    Silva J; Silva JM; García V; García JM; Domínguez G; Bonilla F
    Genes Chromosomes Cancer; 2002 Dec; 35(4):375-6. PubMed ID: 12378534
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.
    Chan KC; Lo YM
    Br J Cancer; 2007 Mar; 96(5):681-5. PubMed ID: 17311021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of DNA aberrations in human cancers by AP-PCR-SSCP analysis].
    Okano A; Sekiya T
    Tanpakushitsu Kakusan Koso; 1996 Apr; 41(5):633-7. PubMed ID: 8650355
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
    Taback B; Hoon DS
    Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.